Drug intelligence / Profile preview

Rebi ointment

Development stage: Preclinical
Lead developer: Yunnan Provincial Hospital of Traditional Chinese Medicine
Modality: Small Molecules
Administration: Topical

Overview

Rebi ointment (热痹膏) is a traditional Chinese medicine (TCM) compound formulated for external application. It is primarily used to treat joint pain associated with rheumatoid arthritis, particularly cases characterized by 'damp-heat syndrome'. The ointment is designed to clear heat and dampness, dispel wind, dredge collaterals, reduce swelling, and relieve pain. Its composition includes a variety of Chinese herbs, and it is currently undergoing clinical evaluation for its efficacy in rheumatoid arthritis.

Other names: Rebi热痹膏

Beyond the preview

Go deeper on Rebi ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rebi ointment.

Explore the full profile